Spravato Treatment

We are a Certified SPRAVATO™ Treatment Center

What is SPRAVATO™?

SPRAVATO™ is a prescription medicine, used along with an antidepressant taken by mouth, for treatment-resistant depression (TRD) in adults.  For additional safety information please visit SPRAVATO’s website here.

We outsource our Spravato services to Greenbrook TMS, housed within our facility.

Why SPRAVATO®

If you’ve taken two or more oral antidepressants and still experience symptoms of depression, you might have treatment-resistant depression(TRD).

It might be time to talk to your doctor about a different treatment approach. See what makes SPRAVATO® different and learn more about other patients’ experiences with SPRAVATO®.

 

Proven Effective for Treatment-Resistant Depression

You may benefit from adding SPRAVATO® to your existing oral antidepressant if you’re an adult with major depressive disorder (MDD) who has had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD).

Adults with treatment-resistant depression who were part of a clinical study were given either a nasal esketamine spray or a placebo spray.

Those who added esketamine, the active ingredient in SPRAVATO®, to their oral antidepressant experienced a greater reduction of depressive symptoms at four weeks compared to those who received placebo plus an oral antidepressant.*

^*Based on an overall score on a standardized rating scale.

If two or more oral antidepressants haven’t worked for you, ask your doctor if adding SPRAVATO® may be able to help.